Organon & Co.
New York Stock ExchangeTotal Valuation
Organon & Co. carries a market capitalization of 3.60B, placing it among publicly traded companies globally. Its enterprise value stands at 10.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.60B |
| Enterprise Value | 10.98B |
Share Statistics
Organon & Co. currently has 262.61M shares outstanding.
| Shares Outstanding | 262.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Organon & Co. trades at a trailing price-to-earnings ratio of 16.89. The price-to-sales ratio is 0.58, and the price-to-book ratio stands at 3.53.
| PE Ratio | 16.89 |
| PS Ratio | 0.58 |
| PB Ratio | 3.53 |
| P/TBV Ratio | -0.83 |
| P/FCF Ratio | 4.10 |
| P/OCF Ratio | 4.79 |
Enterprise Valuation
On an enterprise value basis, Organon & Co. trades at an EV/EBITDA multiple of 7.23 and an EV/FCF ratio of 10.27. The EV/Sales ratio of 1.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.43 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.79 |
| EV / EBITDA | 7.23 |
| EV / EBIT | 9.43 |
| EV / FCF | 10.27 |
Financial Position
Organon & Co. maintains a current ratio of 1.95, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 850.20, indicating elevated leverage, while an interest coverage ratio of 3.24 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.95 |
| Quick Ratio | 1.00 |
| Debt / Equity | 850.20 |
| Debt / EBITDA | 5.63 |
| Interest Coverage | 3.24 |
Financial Efficiency
Organon & Co. posts a return on equity of 24.04 and a return on invested capital of 5.10.
| Return on Equity (ROE) | 24.04 |
| Return on Assets (ROA) | 1.57 |
| Return on Invested Capital (ROIC) | 5.10 |
| Return on Capital Employed (ROCE) | 4.25 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.07 |
Taxes
Over the trailing twelve months, Organon & Co. has paid 282.00M in income taxes, reflecting an effective tax rate of 57.43.
| Income Tax | 282.00M |
| Effective Tax Rate | 57.43 |
Stock Price Statistics
Organon & Co.'s stock has gained approximately 46.11289% over the past 52 weeks. The 50-day moving average sits at 13.50, while the 200-day moving average is 9.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | 46.11289% |
| 50-Day Moving Average | 13.50 |
| 200-Day Moving Average | 9.75 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Organon & Co. generated 6.13B in revenue and converted that into 209.00M in net income, yielding earnings per share of 0.79. EBITDA reached 1.52B, while operating income came in at 1.16B.
| Revenue | 6.13B |
| Gross Profit | 3.23B |
| Operating Income | 1.16B |
| Pretax Income | 491.00M |
| Net Income | 209.00M |
| EBITDA | 1.52B |
| EBIT | 1.16B |
| Earnings Per Share (EPS) | 0.79 |
Balance Sheet
Organon & Co. holds 1.13B in cash and equivalents against 8.55B in total debt, resulting in a net debt position of 7.42B. Total book value stands at 1.01B, with working capital of 2.50B providing operational flexibility.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 8.55B |
| Net Debt | 7.42B |
| Equity (Book Value) | 1.01B |
| Book Value Per Share | 3.83 |
| Working Capital | 2.50B |
Cash Flow
Organon & Co. produced 737.00M in operating cash flow over the past twelve months. After subtracting -133.00M in capital expenditures, free cash flow totaled 604.00M - equivalent to 2.32 per share.
| Operating Cash Flow | 737.00M |
| Capital Expenditures | -133.00M |
| Free Cash Flow | 604.00M |
| FCF Per Share | 2.32 |
Margins
Organon & Co. operates with a gross margin of 52.68, reflecting its pricing power and cost economics. The operating margin of 19.00 and net profit margin of 3.41 provide insight into operational efficiency.
| Gross Margin | 52.68 |
| Operating Margin | 19.00 |
| Pretax Margin | 8.01 |
| Profit Margin | 3.41 |
| EBITDA Margin | 24.78 |
Dividends & Yields
The company's payout ratio of 8.61 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.07 |
| Dividend Yield | N/A |
| Payout Ratio | 8.61 |
| Shareholder Yield | 8.80 |
| FCF Yield | 24.38 |
Scores
Organon & Co. posts an Altman Z-Score of 2.05, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.05 |